To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL LIMITED - Dealings in securities by a director of a major subsidiary

Release Date: 22/01/2014 10:49
Code(s): MDC     PDF:  
Wrap Text
Dealings in securities by a director of a major subsidiary

Mediclinic International Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE000074142
Share Code: MDC

DEALINGS IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY

In compliance with the Listings Requirements of the JSE Limited,
the following information is disclosed:

Director                     :   Dr N S Matlala
Company                      :   Mediclinic Southern Africa (Pty)
                                 Ltd (major subsidiary of
                                 Mediclinic International
                                 Limited)
Date of transaction          :   21 January 2014
Nature of transaction        :   On market sale of securities
Class of securities          :   Ordinary shares
Number of securities         :   5 082
Selling price                :   3 082 at R70.50 per share
                                 2000 at R70.80 per share
Total value of transaction   :   R358 881.00
Nature of interest           :   Direct beneficial
Clearance obtained           :   Yes

Stellenbosch
22 January 2014

Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 22/01/2014 10:49:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story